Status
Conditions
Treatments
About
ARDS is a severe disease in ICU, and could induce high mortality. Glycocalyx is an important matrix construction which covers endothelial cells, it could protect endothelial cells injury and the glycocalyx biomarkers could predict pulmonary injury.
Decorin is a member of the small leucine-rich proteoglycan (SLRP) family, contains a single glycosaminoglycan (GAG) chain and a core protein with 12 leucine-rich repeats. In the previous study, decorin is associated with cardiac and liver fibrosis, however, the effects of decorin on ARDS pulmonary fibrosis have not been clarified.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
336 participants in 3 patient groups
Loading...
Central trial contact
Chun C Pan, Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal